Recent developments in human cytomegalovirus diagnosis (Q36839729)

16 August 2017

1 reference

title

Recent developments in human cytomegalovirus diagnosis (English)

1 reference

16 August 2017

0 references

Gabriele Halwachs-Baumann

series ordinal

1

1 reference

16 August 2017

1 June 2007

1 reference

Expert Review of Anti-infective Therapy

16 August 2017

1 reference

16 August 2017

5

1 reference

16 August 2017

3

1 reference

16 August 2017

427-439

1 reference

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

16 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

The congenital cytomegalovirus infection: virus-host interaction for defense and transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Epidemiology of infections after solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Infection in solid organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Pulmonary complications of solid organ and hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Management of cytomegalovirus infection and disease after solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

New developments in the diagnosis of maternal and congenital CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Molecular techniques should now replace cell culture in diagnostic virology laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Molecular techniques should not now replace cell culture in diagnostic virology laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Sequence diversity in the glycoprotein B gene complicates real-time PCR assays for detection and quantification of cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Human cytomegalovirus load in various body fluids of congenitally infected newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Quantitation of cytomegalovirus DNA in cerebrospinal fluid and serum specimens from AIDS patients using a novel highly sensitive nested competitive PCR and the cobas amplicor CMV monitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Combined-modality therapy in locally advanced primary rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Detection and quantitation of human cytomegalovirus DNA in faeces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Discordant phenotypes and genotypes of cytomegalovirus (CMV) in patients with AIDS and relapsing CMV retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor test for detection of cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Antiviral drugs for cytomegalovirus diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Cytomegalovirus (CMV)-specific cellular immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Clinical Utility of Tetramer-Based Immune Monitoring in Allogeneic Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Clinical utility of CMV early and late transcript detection with NASBA in bronchoalveolar lavages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

CMV DNA in blood and CSF of HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.427

21 January 2018

Identifiers

DOI

10.1586/14787210.5.3.427

1 reference

16 August 2017

1 reference

PubMed ID

17547507